Title : Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.

Pub. Date : 2018 Sep 1

PMID : 30171812






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway. Metformin AKT serine/threonine kinase 1 Homo sapiens